170 related articles for article (PubMed ID: 527656)
1. Differential effects of acute and subacute HA-966 treatment on storage and release of striatal dopamine.
Broxterman HJ; Noach EL; Van Valkenburg CF
Eur J Pharmacol; 1979 Dec; 60(2-3):153-61. PubMed ID: 527656
[TBL] [Abstract][Full Text] [Related]
2. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
Wood PL; Nair NP; Bozarth M
Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
[TBL] [Abstract][Full Text] [Related]
3. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
Elverfors A; Nissbrandt H
Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
[TBL] [Abstract][Full Text] [Related]
4. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
5. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
6. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
7. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
[TBL] [Abstract][Full Text] [Related]
8. Preservation of dopamine release in the denervated striatum.
Altar CA; Marien MR
Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
[TBL] [Abstract][Full Text] [Related]
9. Effects of heterocyclic amines in food on dopamine metabolism in nigro-striatal dopaminergic neurons.
Ichinose H; Ozaki N; Nakahara D; Naoi M; Wakabayashi K; Sugimura T; Nagatsu T
Biochem Pharmacol; 1988 Sep; 37(17):3289-95. PubMed ID: 2900009
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
Commissiong JW; Slimovitch C; Toffano G
Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
Santiago M; Rollema H; de Vries JB; Westerink BH
Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
[TBL] [Abstract][Full Text] [Related]
13. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
16. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
Nguyen TV; Juorio AV; Greenshaw AJ
Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
[TBL] [Abstract][Full Text] [Related]
17. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
18. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
Robinson TE; Whishaw IQ
Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
[TBL] [Abstract][Full Text] [Related]
19. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
Nissbrandt H; Carlsson A
J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites.
Yu ZJ; Lim DK; Hoskins B; Rockhold RW; Ho IK
Neurochem Res; 1990 Jun; 15(6):613-9. PubMed ID: 2215853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
